Effect of Blood Donor Characteristics on Transfusion Outcomes: A Systematic Review and Meta-Analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
WHO, 2014, Blood safety and availability, WHO Glob Database Blood Saf
Gilliss, 2011, Reducing noninfectious risks of blood transfusion, Anesthesiology, 115, 635, 10.1097/ALN.0b013e31822a22d9
Vamvakas, 2009, Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention, Blood, 113, 3406, 10.1182/blood-2008-10-167643
O’Brien, 2012, Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services, Vox Sang, 103, 83, 10.1111/j.1423-0410.2012.01584.x
Toy, 2012, Transfusion-related acute lung injury: incidence and risk factors, Blood, 119, 1757, 10.1182/blood-2011-08-370932
Chapman, 2008, National Blood Service TRALI reduction policies: implementation and effect, Transfus Med Hemother, 35, 93, 10.1159/000119116
Taylor, 2009, Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report—2009, J Heart Lung Transplant, 28, 1007, 10.1016/j.healun.2009.08.014
Bonser, 2012, Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry, Lancet, 380, 747, 10.1016/S0140-6736(12)60160-3
Rayhill, 2007, Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C, Transplantation, 84, 331, 10.1097/01.tp.0000270313.31328.63
Kollman, 2001, Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age, Blood, 98, 2043, 10.1182/blood.V98.7.2043
Schultz, 1994, Obstructive lung disease in children after allogeneic bone marrow transplantation, Blood, 84, 3212, 10.1182/blood.V84.9.3212.3212
Chassé, 2014, Effect of blood donor characteristics on transfusion outcomes: a protocol for systematic review and meta-analysis, Syst Rev, 3, 28, 10.1186/2046-4053-3-28
Higgins, 2011, Cochrane handbook for systematic reviews of interventions
Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD
Gajic, 2007, Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components, Crit Care Med, 35, 1645, 10.1097/01.CCM.0000269036.16398.0D
Edgren, 2007, Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study, Lancet, 369, 1724, 10.1016/S0140-6736(07)60779-X
Lin, 2012, Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services, Transfusion, 52, 567, 10.1111/j.1537-2995.2011.03330.x
Nowlis, 2012, The effect of red blood cell donor age on lung injury development after hemorrhagic trauma, Transfusion, 52, 171A
Porretti, 2012, Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors, Blood Transfus, 10, 351
Petersen, 1994, Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody, Transfusion, 34, 283, 10.1046/j.1537-2995.1994.34494233574.x
Manns, 1992, A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion, Int J cancer, 51, 886, 10.1002/ijc.2910510609
Eder, 2010, Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008), Transfusion, 50, 1732, 10.1111/j.1537-2995.2010.02652.x
Arinsburg, 2012, Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI, Transfusion, 52, 946, 10.1111/j.1537-2995.2011.03403.x
Chapman, 2009, Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma, Transfusion, 49, 440, 10.1111/j.1537-2995.2008.01948.x
Eder, 2012, The residual risk of TRALI in a large U.S. blood system reflects the ongoing reliance on AB plasma from female donors to meet demand, Vox Sang, 103, 20
Poulin, 2011
Insunza, 2004, Implementation of a strategy to prevent TRALI in a regional blood centre, Transfus Med, 14, 157, 10.1111/j.0958-7578.2004.00492.x
Middelburg, 2010, Female donors and transfusion-related acute lung injury, Transfusion, 50, 2447, 10.1111/j.1537-2995.2010.02715.x
Sanchez, 2007, Transfusion-related acute lung injury: a case-control pilot study of risk factors, Am J Clin Pathol, 128, 128, 10.1309/HC4PVY24NJXMQ884
Kulharya, 2001, Packed red cell transfusion does not compromise chromosome analysis in newborns, Genet Med, 3, 314, 10.1097/00125817-200107000-00008
Middelburg, 2011, Mortality after sex-mismatched transfusions, Vox Sang, 101, 314, 10.1111/j.1423-0410.2011.01487.x
Paul, 2011, Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants, Pediatrics, 127, 635, 10.1542/peds.2010-3178
Eder, 2007, Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross, Transfusion, 47, 599, 10.1111/j.1537-2995.2007.01102.x
Middelburg, 2011, Mortality after transfusions, relation to donor sex, Vox Sang, 101, 221, 10.1111/j.1423-0410.2011.01487.x
Vlaar, 2011, The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study, Blood, 117, 4218, 10.1182/blood-2010-10-313973
Zupanska, 2007, Transfusion-related acute lung injury and leucocyte-reacting antibodies, Vox Sang, 93, 70, 10.1111/j.1423-0410.2007.00920.x
Ambruso, 1987, Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy, Transfusion, 27, 94, 10.1046/j.1537-2995.1987.27187121485.x
Heddle, 1992, A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing, Br J Haematol, 81, 579, 10.1111/j.1365-2141.1992.tb02995.x
Michail-Merianou, 1987, Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes, Vox Sang, 52, 95, 10.1111/j.1423-0410.1987.tb02999.x
Tahhan, 1994, Antigen-matched donor blood in the transfusion management of patients with sickle cell disease, Transfusion, 34, 562, 10.1046/j.1537-2995.1994.34794330008.x
Ameen, 2009, Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion, Transfusion, 49, 1649, 10.1111/j.1537-2995.2009.02185.x
van der Mast, 1997, Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation, Transplantation, 63, 1514, 10.1097/00007890-199705270-00024
Hiesse, 2001, Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation, Kidney Int, 60, 341, 10.1046/j.1523-1755.2001.00805.x
Albert, 1981, HLA-A, B matching of pretransplant blood transfusion is associated with poor graft survival, Transplant Proc, 13, 175
Mariat, 2000, Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome, Transplant Proc, 32, 381, 10.1016/S0041-1345(99)00986-0
Christiaans, 1999, HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome, Transplantation, 67, 1029, 10.1097/00007890-199904150-00016
Vervoordeldonk, 1998, Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion, Br J Haematol, 102, 1004, 10.1046/j.1365-2141.1998.00862.x
Middleton, 1994
Baudouin, 1997, Cytotoxic T lymphocyte changes after HLA-DR match and HLA-DR mismatch blood transfusions, Transplantation, 63, 1155, 10.1097/00007890-199704270-00016
Magee, 2012, Effects of HLA-matched blood transfusion for patients awaiting renal transplantation, Transplantation, 94, 1111, 10.1097/TP.0b013e318271d776
Scornik, 1989, Prevention of transfusion-induced broad sensitization in renal transplant candidates, Transplantation, 47, 617, 10.1097/00007890-198904000-00011
van Hooff, 1992, The influence of DR match of blood donor and recipient on the formation of T- and B-cell antibodies and on renal allograft outcome, Transpl Int, 5, S599, 10.1111/tri.1992.5.s1.599
van Twuyver, 1991, Pretransplantation blood transfusion revisited, N Engl J Med, 325, 1210, 10.1056/NEJM199110243251704
Pass, 1976, Evaluation of a walking donor blood transfusion program in an intensive care nursery, J Pediatr, 89, 646, 10.1016/S0022-3476(76)80410-6
Strauss, 2000, Randomized trial assessing the feasibility and safety of biologic parents as RBC donors for their preterm infants, Transfusion, 40, 450, 10.1046/j.1537-2995.2000.40040450.x
Middelburg, 2011, Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study, Transfusion, 51, 2111, 10.1111/j.1537-2995.2011.03118.x
Funk, 2012, Benefit of transfusion-related acute lung injury risk-minimization measures—German haemovigilance data (2006-2010), Vox Sang, 102, 317, 10.1111/j.1423-0410.2011.01556.x
Johnson, 2012, Lookback investigations of Babesia microti–seropositive blood donors: seven-year experience in a Babesia-endemic area, Transfusion, 52, 1509, 10.1111/j.1537-2995.2011.03345.x
Young, 2012, Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program, Transfusion, 52, 1523, 10.1111/j.1537-2995.2012.03612.x
Nichols, 2003, Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products, Blood, 101, 4195, 10.1182/blood-2002-10-3143
Preiksaitis, 1997, Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study, Transfusion, 37, 941, 10.1046/j.1537-2995.1997.37997454022.x
Allain, 2013, Infectivity of blood products from donors with occult hepatitis B virus infection, Transfusion, 53, 1405, 10.1111/trf.12096
Aymard, 1986, Post-transfusion non-A, non-B hepatitis after cardiac surgery. Prospective analysis of donor blood anti-HBc antibody as a predictive indicator of the occurrence of non-A, non-B hepatitis in recipients, Vox Sang, 51, 236, 10.1111/j.1423-0410.1986.tb01961.x
Blajchman, 1995, Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study, Group, 345
Beltran, 2005, Hepatitis C virus seroprevalence in multi-transfused patients in Colombia, J Clin Virol, 34, S33, 10.1016/S1386-6532(05)80032-0
O’Riordan, 1998, Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C, Transfus Med, 8, 303, 10.1046/j.1365-3148.1998.00172.x
2002, Probability of receiving testing in a national lookback program: the English HCV experience, Transfusion, 42, 1140, 10.1046/j.1537-2995.2002.00171.x
Vogt, 2004, Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening, Infection, 32, 134, 10.1007/s15010-004-2209-y
Hladik, 2006, Prevalence and screening costs of hepatitis C virus among Ugandan blood donors, Trop Med Int Health, 11, 951, 10.1111/j.1365-3156.2006.01643.x
Herr, 1993, Transfusion-associated transmission of human T-lymphotropic virus types I and II: experience of a regional blood center, Transfusion, 33, 208, 10.1046/j.1537-2995.1993.33393174445.x
Okochi, 1986, Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention, AIDS Res, 2, S157
Sato, 1992, Transfusion transmitted infection of HTLV-I and its prevention, Gann Monogr Cancer Res, 39, 151